| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $13.9M | +22.5% |
| SG&A Expense | $17.2M | +23.4% |
| Operating Income | -$31.1M | -20.9% |
| Interest Expense | $167K | +1264.8% |
| Income Tax | $0 | — |
| Net Income | -$34.7M | -35.7% |
| EPS (Basic) | -$64.42 | -2750.4% |
| EPS (Diluted) | -$64.42 | -2750.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $645K | -97.5% |
| Accounts Receivable | $16K | +0.0% |
| Current Assets | $1.7M | -93.8% |
| Total Assets | $12.0M | -61.1% |
| Current Liabilities | $13.3M | +289.6% |
| Total Liabilities | $17.7M | +420.3% |
| Stockholders' Equity | -$5.8M | -121.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$23.7M | -16.9% |
| Capital Expenditures | $4.9M | +157.6% |
| Investing Cash Flow | -$4.9M | -168.7% |
| Financing Cash Flow | $3.9M | -89.5% |
| Free Cash Flow | -$28.6M | -28.9% |